Background illustration for clinical trials search

Paid Clinical Trials Little Rock

Discover 471 paid clinical trials in Little Rock, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

for
Duchenne Muscular Dystrophy
Location: Little Rock AR, St Louis MO, Atlanta GA, Chicago IL,
Sponsor: Solid Biosciences Inc.

Sex: Male

Age: 0 - 17

Code: NCT06138639

Phase1, Phase2, Recruiting

Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care

for
Primary Ciliary Dyskinesia
Location: Little Rock AR
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 2 - 70+

Code: NCT05287022

Recruiting

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

for
Deep Venous Thrombosis
Location: Little Rock AR, St Louis MO, Dallas TX,
Sponsor: Yale University

Sex: All

Age: 0 - 17

Code: NCT04924322

Phase2, Phase3, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Little Rock AR, Memphis TN, Jackson MS, Tulsa OK,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase3, Recruiting

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

for
Type 2 Diabetes
Location: Little Rock AR, Jackson MS, Dallas TX, Oklahoma City OK,
Sponsor: Eli Lilly and Company

Sex: All

Age: 10 - 17

Code: NCT06739122

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

ASC618 Gene Therapy in Hemophilia A Patients

for
Hemophilia A
Location: Little Rock AR
Sponsor: ASC Therapeutics

Sex: Male

Age: 18+

Code: NCT04676048

Phase1, Phase2, Recruiting

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

for
Medulloblastoma
Location: Little Rock AR, St Louis MO, Oklahoma City OK,
Sponsor: Giselle Sholler

Sex: All

Age: 0 - 21

Code: NCT04696029

Phase2, Recruiting

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy

for
Congenital Myotonic Dystrophy
Location: Little Rock AR, Iowa City IA, Chicago IL, Pittsburgh PA,
Sponsor: AMO Pharma Limited

Sex: All

Age: 6 - 45

Code: NCT05004129

Phase2, Phase3, Recruiting

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

for
Amblyopia
Location: Little Rock AR, Memphis TN, Prairie Village KS,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 8 - 12

Code: NCT06524882

Phase3, Recruiting

Quality of End-of-Life Care for Children With Cancer

for
Childhood Hematopoietic and Lymphatic System Neoplasm,
Location: Little Rock AR, Dallas TX, Birmingham AL,
Sponsor: Children's Oncology Group

Sex: All

Age: 18+

Code: NCT07412002

Recruiting

Mitochondrial Energy Metabolism in Burns

for
Burn Injury
Location: Little Rock AR
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 2 - 70+

Code: NCT07643545

Recruiting

PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)

for
Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD,
Location: Little Rock AR, St Louis MO
Sponsor: Precision BioSciences, Inc.

Sex: Male

Age: 2 - 7

Code: NCT07429240

Phase1, Phase2, Recruiting

A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab

for
B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia,
Location: Little Rock AR, Springdale AR
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 1 - 23

Code: NCT07422337

Recruiting

De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

for
Congenital Diaphragmatic Hernia
Location: Little Rock AR, Memphis TN, Nashville TN, Birmingham AL,
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 0

Code: NCT05213676

Recruiting

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort

for
Duchenne Muscular Dystrophy
Location: Little Rock AR, St Louis MO, Flower Mound TX,
Sponsor: Sarepta Therapeutics, Inc.

Sex: Male

Age: 2+

Code: NCT04626674

Phase1, Recruiting

Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

for
Duchenne Muscular Dystrophy
Location: Little Rock AR, Atlanta GA
Sponsor: Wave Life Sciences Ltd.

Sex: Male

Age: 4 - 18

Code: NCT04906460

Phase1, Phase2, Recruiting

Non-invasive Prediction of EArly Cardiac rEjection

for
Heart Transplant, Pediatric Heart Transplant, Rejection,
Location: Little Rock AR, St Louis MO, Nashville TN, Houston TX,
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 6 - 25

Code: NCT07770659

Recruiting

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

for
Ig-E Mediated Food Allergy
Location: Little Rock AR, Nashville TN, Houston TX, Austin TX,
Sponsor: RAPT Therapeutics, Inc.

Sex: All

Age: 12 - 55

Code: NCT07220811

Phase2, Recruiting

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

for
Atypical Teratoid/Rhabdoid Tumor,
Location: Little Rock AR, St Louis MO, Dallas TX, Nashville TN,
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 0 - 26

Code: NCT06465199

Phase1, Phase2, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Little Rock AR, Jackson MS, St Louis MO, Dallas TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase3, Recruiting